Fam107a inactivation associated with promoter methylation affects prostate cancer progression through the fak/pi3k/akt pathway

HIGHLIGHTS

  • who: Shuai Ke and collaborators from the Department of Urology, Renmin Hospital of Wuhan University, Zhangzhidong Road, Wuhan, China have published the research work: FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway, in the Journal: Cancers 2022, 3915 of /2022/
  • what: The authors provide clear evidence that FAM107A acts as a downregulated gene in PCa.

SUMMARY

    The level of FAM107A protein in laryngeal squamous cell carcinoma is lower than that in normal tissues due to hypermethylation of the promoter region. Overexpression of FAM107A . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?